Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Standard of Care in Elderly cSSTI
NCT01184872Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of daptomycin in skin and soft tissue infections (SSTIs), sponsored by Novartis. Started Mar 2010; status: completed.
02
Drugs
daptomycin
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on NCT01184872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184872.